Posted in | News | Signal Processing

AMRAAM Integrated with JLENS Sensor System Intercepts Anti-Ship Cruise Missile Surrogate

The U.S. Army and U.S. Air Force intercepted for the first time an anti-ship cruise missile surrogate using Raytheon Company's Advanced Medium Range Air-to-Air Missile (AMRAAM) cued by JLENS. An affordable, elevated, persistent over-the-horizon sensor system, JLENS uses a powerful integrated radar system to detect, track and target a variety of threats.

"Integrating JLENS' precision detection and targeting information with the combat-proven AMRAAM gives our military a new way to defend the fleet and our allies from anti-ship cruise missiles that threaten vital waterways and critical chokepoints," said Dave Gulla, vice president of Global Integrated Sensors for Raytheon's Integrated Defense Systems business.

During the July 17 test, the Army's JLENS acquired and tracked an anti-ship cruise missile surrogate and passed targeting data to an Air Force F-15E via Link 16, enabling the fighter pilot to fire an AIM-120C7 AMRAAM, culminating in the weapon intercepting the target, meeting all test objectives.

"JLENS has proven it can defend and extend the battlespace by integrating with Patriot, Standard Missile-6, and now AMRAAM," said Dean Barten, the U.S. Army's JLENS product manager. "This test enhances the cruise missile defense umbrella, and when this capability is deployed, it will help save lives."

"Integrating AMRAAM with JLENS enables the world's most capable air-to-air missile to engage targets at the weapon's maximum kinematic range," said Harry Schulte, vice president of Raytheon Missile Systems' Air Warfare Systems. "This test further demonstrates AMRAAM's operational flexibility and provides today's warfighter with enhanced operational capability, cost effectiveness and future growth solutions."

About JLENS
JLENS consists of an integrated surveillance and fire-control radar on two tethered, 74-meter aerostats, which fly at altitudes of 10,000 feet above sea level and remain aloft and operational for 30 days. This capability better enables commanders to defend against threats including hostile cruise missiles, low-flying manned and unmanned aircraft, and moving surface vehicles such as boats, mobile missile launchers, automobiles, trucks and tanks. JLENS also provides ascent phase detection of tactical ballistic missiles and large-caliber rockets.

About AMRAAM
AMRAAM is a combat-proven missile that has demonstrated operational flexibility in both air-to-air and surface-launch engagement scenarios and provides today's warfighter with enhanced operational capability, cost effectiveness and future growth options and solutions. Procured by 36 countries, the combat-proven AMRAAM has been operational and integrated on the F-16, F-15, F/A-18, F-22, Typhoon, Gripen, Tornado, Harrier and F-4, and integration is ongoing in the Joint Strike Fighter aircraft. It is also the baseline missile for the NATO-approved National Advanced Surface-to-Air Missile System.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Raytheon Company. (2022, June 24). AMRAAM Integrated with JLENS Sensor System Intercepts Anti-Ship Cruise Missile Surrogate. AZoSensors. Retrieved on June 17, 2024 from https://www.azosensors.com/news.aspx?newsID=6386.

  • MLA

    Raytheon Company. "AMRAAM Integrated with JLENS Sensor System Intercepts Anti-Ship Cruise Missile Surrogate". AZoSensors. 17 June 2024. <https://www.azosensors.com/news.aspx?newsID=6386>.

  • Chicago

    Raytheon Company. "AMRAAM Integrated with JLENS Sensor System Intercepts Anti-Ship Cruise Missile Surrogate". AZoSensors. https://www.azosensors.com/news.aspx?newsID=6386. (accessed June 17, 2024).

  • Harvard

    Raytheon Company. 2022. AMRAAM Integrated with JLENS Sensor System Intercepts Anti-Ship Cruise Missile Surrogate. AZoSensors, viewed 17 June 2024, https://www.azosensors.com/news.aspx?newsID=6386.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.